These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10588996)

  • 1. Montelukast, a leukotriene receptor antagonist, reduces the concentration of leukotrienes in the respiratory tract of children with persistent asthma.
    Volovitz B; Tabachnik E; Nussinovitch M; Shtaif B; Blau H; Gil-Ad I; Weizman A; Varsano I
    J Allergy Clin Immunol; 1999 Dec; 104(6):1162-7. PubMed ID: 10588996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma.
    Diamant Z; Grootendorst DC; Veselic-Charvat M; Timmers MC; De Smet M; Leff JA; Seidenberg BC; Zwinderman AH; Peszek I; Sterk PJ
    Clin Exp Allergy; 1999 Jan; 29(1):42-51. PubMed ID: 10051701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma.
    Stelmach I; Jerzynska J; Kuna P
    J Allergy Clin Immunol; 2002 Feb; 109(2):257-63. PubMed ID: 11842294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma.
    Yüksel B; Aydemir C; Ustündag G; Eldeş N; Kutsal E; Can M; Demirtaş S; Tomaç N
    Turk J Pediatr; 2009; 51(5):460-5. PubMed ID: 20112601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
    Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
    Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial on the effect of montelukast on sputum eosinophil cationic protein in children with corticosteroid-dependent asthma.
    Strauch E; Moske O; Thoma S; Storm Van's Gravesande K; Ihorst G; Brandis M; Kuehr J
    Pediatr Res; 2003 Aug; 54(2):198-203. PubMed ID: 12736396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: a 56-week randomized double-blind study.
    Becker AB; Kuznetsova O; Vermeulen J; Soto-Quiros ME; Young B; Reiss TF; Dass SB; Knorr BA;
    Ann Allergy Asthma Immunol; 2006 Jun; 96(6):800-7. PubMed ID: 16802767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory effects of montelukast in mild cystic fibrosis.
    Schmitt-Grohé S; Eickmeier O; Schubert R; Bez C; Zielen S
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):599-605. PubMed ID: 12487226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
    Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
    Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast.
    Minoguchi K; Kohno Y; Minoguchi H; Kihara N; Sano Y; Yasuhara H; Adachi M
    Chest; 2002 Mar; 121(3):732-8. PubMed ID: 11888953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Montelukast 10 mg improves nasal function and nasal response to aspirin in ASA-sensitive asthmatics: a controlled study vs placebo.
    Micheletto C; Tognella S; Visconti M; Pomari C; Trevisan F; Dal Negro RW
    Allergy; 2004 Mar; 59(3):289-94. PubMed ID: 14982510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Montelukast: a review of its therapeutic potential in persistent asthma.
    Jarvis B; Markham A
    Drugs; 2000 Apr; 59(4):891-928. PubMed ID: 10804041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of triamcinolone acetonide, montelukast, nedocromil sodium and formoterol on eosinophil blood counts, ECP serum levels and clinical progression of asthma in children].
    Stelmach I; Grzelewski T; Stelmach W; Majak P; Jerzyńska J; Górski P; Kuna P
    Pol Merkur Lekarski; 2002 Mar; 12(69):208-13. PubMed ID: 12053590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a cysteinyl leukotriene receptor antagonist on experimental emphysema and asthma combined with emphysema.
    Ikeda G; Miyahara N; Koga H; Fuchimoto Y; Waseda K; Kurimoto E; Taniguchi A; Tanimoto Y; Kataoka M; Tanimoto M; Kanehiro A
    Am J Respir Cell Mol Biol; 2014 Jan; 50(1):18-29. PubMed ID: 23937413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma.
    Sandrini A; Ferreira IM; Gutierrez C; Jardim JR; Zamel N; Chapman KR
    Chest; 2003 Oct; 124(4):1334-40. PubMed ID: 14555563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects.
    Schmitt-Grohé S; Zielen S
    Paediatr Drugs; 2005; 7(6):353-63. PubMed ID: 16356023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montelukast inhibits interleukin-5 mRNA expression and cysteinyl leukotriene production in ragweed and mite-stimulated peripheral blood mononuclear cells from patients with asthma.
    Frieri M; Therattil J; Wang SF; Huang CY; Wang YC
    Allergy Asthma Proc; 2003; 24(5):359-66. PubMed ID: 14619337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Montelukast regulates eosinophil protease activity through a leukotriene-independent mechanism.
    Langlois A; Ferland C; Tremblay GM; Laviolette M
    J Allergy Clin Immunol; 2006 Jul; 118(1):113-9. PubMed ID: 16815146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma.
    Lazarus SC; Chinchilli VM; Rollings NJ; Boushey HA; Cherniack R; Craig TJ; Deykin A; DiMango E; Fish JE; Ford JG; Israel E; Kiley J; Kraft M; Lemanske RF; Leone FT; Martin RJ; Pesola GR; Peters SP; Sorkness CA; Szefler SJ; Wechsler ME; Fahy JV;
    Am J Respir Crit Care Med; 2007 Apr; 175(8):783-90. PubMed ID: 17204725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Montelukast decreases plasma endothelin-1 and serum eosinophil cationic protein levels in paediatric atopic asthma.
    Kopriva F; Janostáková A; Jarmila S; Zápalka M; Hajduch M
    Clin Drug Investig; 2006; 26(6):351-6. PubMed ID: 17163269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.